Ling Zhang is a seasoned professional in clinical pharmacology and drug development with extensive experience at AstraZeneca and Novartis. From October 2021 to December 2023, Ling served as a Senior Clinical Pharmacologist I at AstraZeneca, focusing on clinical pharmacology and pharmacometrics. Prior to that, from August 2018 to August 2020, Ling held various roles at Novartis, including Senior Scientist in Global Drug Development, specializing in formulation development, and Scientist, where the focus was on preformulation development. Ling started the career as a Rotation Scientist in Clinical Pharmacology at NIBR. Currently, since January 2024, Ling holds the position of Senior Clinical Pharmacologist II at AstraZeneca. Academic qualifications include a PhD in Biology from Tsinghua University and a Visiting Scholar experience in Pharmaceutical Sciences at the University of Michigan.
This person is not in the org chart
This person is not in any teams
This person is not in any offices